Frank Osterroth

511 total citations
11 papers, 250 citations indexed

About

Frank Osterroth is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Frank Osterroth has authored 11 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Frank Osterroth's work include Immunotherapy and Immune Responses (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Frank Osterroth is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Frank Osterroth collaborates with scholars based in Germany and United States. Frank Osterroth's co-authors include Hendrik Veelken, Paul Fisch, Annette I. Garbe, Sundar Jagannath, Kenneth C. Anderson, Andrea Wartenberg‐Demand, Nikhil C. Munshi, Robert J. Lutz, Christoph Uherek and Todd M. Zimmerman and has published in prestigious journals such as Blood, Journal of Immunological Methods and Immunology and Cell Biology.

In The Last Decade

Frank Osterroth

11 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Osterroth Germany 8 135 114 94 77 69 11 250
Torben Altmann Germany 5 131 1.0× 190 1.7× 66 0.7× 56 0.7× 78 1.1× 8 253
GT Stevenson United Kingdom 8 198 1.5× 83 0.7× 193 2.1× 101 1.3× 91 1.3× 10 336
Phillip A. Hsieh United States 8 103 0.8× 239 2.1× 81 0.9× 154 2.0× 211 3.1× 16 339
Sabarinath Venniyil Radhakrishnan United States 12 112 0.8× 219 1.9× 39 0.4× 119 1.5× 128 1.9× 28 332
Bernadette Hilgarth Austria 5 47 0.3× 126 1.1× 47 0.5× 191 2.5× 233 3.4× 7 315
Michael Kilian Germany 6 103 0.8× 140 1.2× 46 0.5× 86 1.1× 61 0.9× 15 253
Simon Steiger Germany 5 82 0.6× 146 1.3× 52 0.6× 96 1.2× 110 1.6× 6 242
Robyn Clark United States 6 177 1.3× 284 2.5× 258 2.7× 121 1.6× 21 0.3× 9 408
Jean Christophe Bories France 8 236 1.7× 92 0.8× 36 0.4× 126 1.6× 43 0.6× 16 350
Rassol Laleau United States 4 32 0.2× 164 1.4× 104 1.1× 86 1.1× 73 1.1× 6 245

Countries citing papers authored by Frank Osterroth

Since Specialization
Citations

This map shows the geographic impact of Frank Osterroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Osterroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Osterroth more than expected).

Fields of papers citing papers by Frank Osterroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Osterroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Osterroth. The network helps show where Frank Osterroth may publish in the future.

Co-authorship network of co-authors of Frank Osterroth

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Osterroth. A scholar is included among the top collaborators of Frank Osterroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Osterroth. Frank Osterroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
König, Martin, Benjamin Dälken, André Engling, et al.. (2014). A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway. Immunology and Cell Biology. 93(4). 396–405. 29 indexed citations
2.
Heffner, Leonard T., Sundar Jagannath, Todd M. Zimmerman, et al.. (2012). BT062, an Antibody-Drug Conjugate Directed Against CD138, Given Weekly for 3 Weeks in Each 4 Week Cycle: Safety and Further Evidence of Clinical Activity. Blood. 120(21). 4042–4042. 50 indexed citations
3.
Jagannath, Sundar, Asher Chanan‐Khan, Leonard T. Heffner, et al.. (2011). BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma. Blood. 118(21). 305–305. 41 indexed citations
4.
Jagannath, Sundar, Asher Chanan‐Khan, Leonard T. Heffner, et al.. (2010). BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity In a Phase I Study In Patients with Relapsed or Relapsed/Refractory Multiple Myeloma. Blood. 116(21). 3060–3060. 10 indexed citations
5.
Aigner, Silke, Olga Ab, Kathleen R. Whiteman, et al.. (2010). BT062, a CD138-Specific Immunoconjugate, Demonstrates Superior In Vivo Anti-Myeloma Efficacy In Combination with Lenalidomide or Bortezomib. Blood. 116(21). 3008–3008. 5 indexed citations
6.
Trollmo, Christina, Christian Becker, Helmut Jonuleit, et al.. (2010). (1125) - Selective Activation of Naturally Occurring Regulatory T Cells (Tregs) by the Monoclonal Antibody (mAb) BT-061. Markers of Clinical Activity and Early Phase II Results in Patients with Rheumatoid Arthritis (RA). 4 indexed citations
7.
Zuber, Chantal, Benjamin Dälken, Silke Aigner, et al.. (2010). 226 High in vivo anti-tumor activity of the immunoconjugate BT-062 against CD138 positive solid tumors. European Journal of Cancer Supplements. 8(7). 74–74. 1 indexed citations
8.
Zirlik, Katja, et al.. (2006). Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli. European Journal Of Haematology. 77(5). 395–402. 17 indexed citations
9.
Veelken, Hendrik & Frank Osterroth. (2002). Vaccination Strategies in the Treatment of Lymphomas. Oncology. 62(3). 187–200. 7 indexed citations
10.
Osterroth, Frank, Annette I. Garbe, Paul Fisch, & Hendrik Veelken. (2000). Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells. Blood. 95(4). 1342–1349. 58 indexed citations
11.
Osterroth, Frank, Andréas Mackensen, A. Lindemann, et al.. (1999). Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination. Journal of Immunological Methods. 229(1-2). 141–153. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torben Altmann Breakdown of academic impact, for papers by GT Stevenson Breakdown of academic impact, for papers by Phillip A. Hsieh Breakdown of academic impact, for papers by Sabarinath Venniyil Radhakrishnan Breakdown of academic impact, for papers by Bernadette Hilgarth Breakdown of academic impact, for papers by Michael Kilian Breakdown of academic impact, for papers by Simon Steiger Breakdown of academic impact, for papers by Robyn Clark Breakdown of academic impact, for papers by Jean Christophe Bories Breakdown of academic impact, for papers by Rassol Laleau
Rankless by CCL
2026